SEC Filing Analysis: FATE THERAPEUTICS INC (FATE)

Executive Summary

• Trading Significance: Low
• Key Takeaway: CFO Kamal Adawi disposed of 6,582 shares valued at ~$13.5K under a mandatory sell-to-cover tax obligation upon RSU vesting.
• Market Impact: Neutral; routine administrative disposition with negligible market exposure.

Company Information

Field	Value
Company	FATE THERAPEUTICS INC
Ticker Symbol	FATE
CIK	0001434316
Industry	Biological Products (No Diagnostic Substances) [2836]

Insider Information

Field	Value
Name	Adawi Kamal
CIK	0001788393
Title/Position	Chief Financial Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-11-03
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	6,582
Price Per Share	$2.0548
Total Value	$13,524.69
Shares Owned After	93,418
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$13,524.69
% of Market Cap	0.0054%
Shares Transacted	6,582
% of Shares Outstanding	0.0055%
Post-Transaction Ownership	93,418 shares (0.078% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: Across Fate Therapeutics' $250M market capitalization, this $13.5K transaction is immaterial and well below any threshold of market relevance.
• Ownership Concentration: The CFO retains 93,418 direct shares (0.078% of outstanding common stock), preserving the vast majority of his equity stake.
• Dilution Impact: The transaction follows an RSU tranche vest of 18,750 shares, representing minimal dilution (<0.02% of outstanding shares).
• Transaction Significance: Categorized as Low significance because the transaction amounts to <0.1% of market cap and shares outstanding, driven strictly by non-discretionary tax withholding.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Automatic sell-to-cover transactions for tax obligations do not communicate an insider's directional sentiment on future equity performance.

Volume & Sentiment

• Expected Volume Impact: Negligible; 6,582 shares represents minimal fraction of typical daily equity volume.
• Sentiment Indicator: Neutral

Additional Context

Transaction Notes

• Special Circumstances: The disposition was an automatic, non-discretionary execution to satisfy tax withholding obligations following the vesting of 18,750 RSUs granted on October 20, 2025. Shares were sold at a volume-weighted average price ranging from $2.020 to $2.084.